Data / Form D filings / Synlico Inc.
Synlico Inc.: Form D filings
Synlico Inc., a biotechnology company in South San Francisco, CA, filed 4 Form D notices with the SEC between 2021 and 2025. The latest, on February 25, 2025, reports $3 million sold of a $3 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 329 Oyster Point Blvd Fl 3, South San Francisco, CA, 94080
- Phone
- (510) 898-6664
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1880583
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 25, 2025 | New notice | $3,000,000 | $3,000,000 | 1 | Feb 24, 2025 | sec.gov | |
| Mar 28, 2023 | Amendment | $1,000,000 | $240,000 | $760,000 | 1 | Mar 11, 2023 | sec.gov |
| Mar 20, 2023 | New notice | $1,000,000 | $240,000 | $760,000 | 1 | Mar 11, 2023 | sec.gov |
| Aug 27, 2021 | New notice | $2,000,040 | $2,000,040 | 2 | Aug 20, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jingwei Lu | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Feb 24, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Synlico Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.